Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Haverkamp

Showing results (161-170 of 165) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 165 results.
Circulation|February 9, 1999
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part IIIS G Priori, J Barhanin, R N Hauer, et al.
Circulation|February 2, 1999
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and IIS G Priori, J Barhanin, R N Hauer, et al.
Leukemia|March 6, 2013
Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinibT D Kim, D Rea, M Schwarz, et al.
British Journal of Pharmacology|July 30, 2008
International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointesA S Bass, B Darpo, A Breidenbach, et al.
Circulation|January 4, 2001
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmiasP J Schwartz, S G Priori, C Spazzolini, et al.
Pageof 17

Showing results (161-170 of 165) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 165 results.
Circulation|February 9, 1999
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part IIIS G Priori, J Barhanin, R N Hauer, et al.
Circulation|February 2, 1999
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and IIS G Priori, J Barhanin, R N Hauer, et al.
Leukemia|March 6, 2013
Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinibT D Kim, D Rea, M Schwarz, et al.
British Journal of Pharmacology|July 30, 2008
International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointesA S Bass, B Darpo, A Breidenbach, et al.
Circulation|January 4, 2001
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmiasP J Schwartz, S G Priori, C Spazzolini, et al.
Pageof 17